Careers with the School of Pharmacy
School of Pharmacy
10A Victoria St. S.
Kitchener, Ontario, Canada N2G 1C5
Find the extension of the person you are looking to reach under Our People.
Dr. Nagge’s clinical and research interests include cardiovascular risk reduction, anticoagulation therapy, translating evidence into practice, and shared decision making.
Contact information
Office: PHR 5001
Phone: 519-888-4567, ext.21312
Email: jnagge@uwaterloo.ca
Dr. Nagge’s primary research interests are driven by questions routinely encountered in his clinical practice that lack solutions supported by a solid evidence base. Examples of this include the development of strategies to optimize the management of anticoagulation therapy, and evaluating the effectiveness and safety of various pharmacological alternatives for cardiovascular risk reduction.
Dr. Nagge also practices as a clinical consultant at the Centre for Family Medicine Academic Family Health team in Kitchener.
His clinical interests include anticoagulation, cardiovascular therapeutics, evidence-informed practice, and shared decision-making. He practices as a clinical consultant at the Centre for Family Medicine Academic Family Health team in Kitchener, where he developed several innovative clinical services including a point-of-care anticoagulation clinic, arterial and venous thrombosis clinics, and a cardiovascular risk reduction clinic. He has supervised hundreds of undergraduate and post-graduate Pharmacy and Medical learners in these clinics, and trained more than 200 practicing pharmacists, nurses and nurse practitioners in MOAT, a blended-learning, continuing education course that teaches clinicians how to manage oral anticoagulant therapy in primary care settings.
Dr. Nagge teaches both undergraduate courses and continuing education courses. Course offerings have included:
PHARM 422: Integrated Patient Focused Care-9
PHARM 495: Advanced topics in Patient Focused Care
PHARM-MOAT: Management of Oral Anticoagulant Therapy
Sridhar V, Ho-Yan Leung P, Seymour N, Nagge J. Evaluation of a 4mg warfarin initiation protocol for atrial fibrillation in the outpatient Setting. Canadian Family Physician. Canadian Family Physician 2014;60:e535-40.
Dhalla IA, Gomes T, Yao Z, Nagge J, Persaud N, Hellings C, Mamdani MM, Juurlink DN. Chlorthalidone versus hydrochlorothiazide for the treatment of hypertension in older adults: A population-based cohort study. Annals of Internal Medicine 2013;158(6):447-455.
Nagge J, Juurlink DN. A population-based comparison of the cardiovascular protective effects of hydrochlorothiazide and chlorthalidone. Circulation. 2007;116:459.
Nagge J, Knowles S, Shear N, Juurlink D. Pseudoephedrine-induced toxic epidermal necrolysis. Archives of Dermatology 2005;141:907-8.
Nagge J, Jackevicius C, Dzavik V, Ross J, Seidelin P. Acute profound thrombocytopenia associated with eptifibatide therapy. Pharmacotherapy 2003; 374-9.
Nagge J, Crowther M, Hirsh J. Is renal impairment a contraindication to the use of low molecular weight heparin? Archives of Internal Medicine 2002;162:2605-9.
2004 PharmD, University of Toronto, Canada
2000 BScPhm, University of Toronto, Canada
1995 BSc (Honours Science, Minor in Chemistry), University of Waterloo, Canada
Careers with the School of Pharmacy
School of Pharmacy
10A Victoria St. S.
Kitchener, Ontario, Canada N2G 1C5
Find the extension of the person you are looking to reach under Our People.
The University of Waterloo acknowledges that much of our work takes place on the traditional territory of the Neutral, Anishinaabeg and Haudenosaunee peoples. Our main campus is situated on the Haldimand Tract, the land granted to the Six Nations that includes six miles on each side of the Grand River. Our active work toward reconciliation takes place across our campuses through research, learning, teaching, and community building, and is centralized within our Office of Indigenous Relations.